详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Y. Cheng[1] * ; J.C-H. Yang[2] ; I. Okamoto[3] ; L. Zhang[4] ; J. Hu[5] ; Y. Cheng[1] ; J.C-H. Yang[2] ; I. Okamoto[3] ; L. Zhang[4] ; J. Hu[5] ; D. Wang[6] ; C. Hu[7] ; J. Zhou[8] ; L. Wu[9] ; L. Cao[10] ; J. Liu[11] ; H. Zhang[12] ; H. Sun[13] ; Z. Wang[14] ; H. Gao[15] ; Y. Yan[16] ; S. Xiao[16] ; J. Lin[17] ; M.C. Pietanza[17] ; T. Kurata[18] ; D. Wang[6] ; C. Hu[7] ; J. Zhou[8] ; L. Wu[9] ; L. Cao[10] ; J. Liu[11] ; H. Zhang[12] ; H. Sun[13] ; Z. Wang[14] ; H. Gao[15] ; Y. Yan[16] ; S. Xiao[16] ; J. Lin[17] ; M.C. Pietanza[17] ; T. Kurata[18] ;

机构： [1]Department of Medical Oncology, Jilin Cancer Hospital, Chaoyang Borough, Changchun, China [2]Department of Oncology, National Taiwan University Hospital andNational Taiwan University Cancer Center, Taipei, Taiwan [3]Graduate School ofMedical Sciences, Kyushu University Hospital, Fukuoka, Japan [4]Respiratory MedicineDepartment, Peking Union Medical College Hospital, Beijing, China [5]Department ofPulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China [6]Department of Oncology, Chongqing Cancer Hospital, Chongqing, China [7]Department of Respirology and Critical Care Medicine, Xiangya Hospital Central SouthUniversity, Changsha, China [8]Department of Respiratory Diseases, The First AffiliatedHospital of Zhejiang University, Hangzhou, China [9]Department of Thoracic Medicine,Hunan Cancer Hospital, Changsha, China [10]Department of Respiration, The FirstAffiliated Hospital of University of Science and Technology of China (Anhui ProvincialHospital), Hefei, China [11]Department of Oncology, The First Affiliated Hospital ofDalian Medical University, Dalian, China [12]Department of Oncology, Tang Du Hospital, The Fourth Military Medical University, Xi’an, China [13]Department of Oncology,The First Affiliated Hospital of Xi’An Jiaotong University, Xi’an, China [14]Department ofThoracic Medical Oncology, Beijing Cancer Hospital, Beijing, China [15]Department ofPulmonary Oncology, Affiliated Hospital of Academy of Military Medical Sciences,Beijing, China [16]Department of Medical Oncology, MSD, Shanghai, China [17]Department of Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA [18]Department ofThoracic Oncology, Kansai Medical University Hospital, Osaka, Japan

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2021]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Medical Oncology, Jilin Cancer Hospital, Chaoyang Borough, Changchun, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Pembrolizumab plus chemotherapy vs chemotherapy in Asian patients with PD-L1 negative advanced NSCLC: Pooled analysis of KN021G, KN189 and KN407

文献详情